Related by context. All words. (Click for frequent words.) 73 cytotoxicity 70 chemotherapeutic drug 70 chemotherapeutics 69 antitumor 69 immunomodulatory 68 chemotherapeutic agents 68 cytostatic 68 antineoplastic 67 proteasome inhibitors 67 chemotherapeutic 67 EGF receptor 67 cytoprotective 67 chemotherapeutic drugs 67 doxorubicin 67 molecularly targeted 67 cytotoxic agents 66 etoposide 66 tumorigenic 66 alkylating agent 66 antitumoral 66 immunomodulating 66 bleomycin 66 selective inhibition 65 antitumor activity 65 induce apoptosis 65 taxol 65 erlotinib Tarceva ® 65 vinca alkaloid 65 anticancer agent 65 effector function 65 potent cytotoxic 65 potent anticancer 65 bortezomib 65 idarubicin 65 HDAC inhibition 65 chemotherapeutic agent 65 Cisplatin 65 immunomodulator 65 tyrosine kinase inhibitor 65 microtubule targeting 65 microtubule inhibitor 65 arsenic trioxide 65 xenograft models 65 anti proliferative 65 interferon IFN 65 EGFr 65 anticancer 64 anticancer agents 64 deacetylase inhibitors 64 HDACi 64 echinocandins 64 taxanes 64 VEGF receptor 64 GM CSF 64 enzyme inhibitor 64 Interferon alpha 64 pharmacokinetic interactions 64 antiangiogenic 64 Gefitinib 64 vinca alkaloids 64 antitumor effects 64 cisplatin 64 antiproliferative 64 pro apoptotic 64 anti mitotic 64 TNFa 64 antibody fragment 64 Trastuzumab 64 immunostimulatory 64 5FU 64 erythropoietic 64 mTOR inhibitors 63 trabectedin 63 anticancer activity 63 Vidofludimus 63 prodrug 63 Pemetrexed 63 anti leukemic 63 taxane 63 humanized antibody 63 induces apoptosis 63 topoisomerase II 63 novel anticancer 63 CCR2 63 milatuzumab 63 EGFR tyrosine kinase inhibitors 63 cytotoxic chemotherapy 63 inhibitory effects 63 nucleoside analogs 63 immunomodulatory effects 63 YONDELIS 63 antiinflammatory 63 SERMs 63 vascular disrupting agents 63 antitumor effect 63 proteasome inhibitor 63 Xanafide 63 tubulin binding 63 interleukins 63 selective inhibitor 63 imatinib Gleevec 63 selective antagonist 63 orally bioavailable 63 pegylated 63 p# inhibitors 63 potent antiproliferative 63 beta lactam 63 vinblastine 63 paclitaxel Taxol 63 DOXIL 63 Doxorubicin 63 Etoposide 63 peptide antigens 63 monoclonal 62 trastuzumab Herceptin ® 62 anticancer drugs 62 PI3K inhibitor 62 intravesical 62 enzyme inhibitors 62 vinorelbine 62 ganciclovir 62 ligand TRAIL 62 nucleoside analogues 62 humanized monoclonal antibody 62 IAP inhibitor 62 Preclinical studies suggest 62 TNF α 62 oncolytic 62 novel peptide 62 selectively inhibit 62 Erlotinib 62 HSP# inhibitor 62 photosensitizer 62 fibrinolytic 62 anti angiogenic 62 potent inhibitory 62 multitargeted 62 cathepsin B 62 inhibit tumor 62 nanomolar 62 histone deacetylase inhibitor 62 vincristine 62 Omacetaxine mepesuccinate 62 topoisomerase 62 muscarinic 62 azacytidine 62 apoptotic 62 immunosuppressive 62 chemotherapeutic treatments 62 peroxidase 62 proteins peptides 62 calcineurin inhibitors 62 lytic 62 inhibiting tumor 62 myeloma cells 62 UsiRNAs 62 bactericidal 62 nucleoside 62 CD# monoclonal antibody 62 antimetabolite 62 cytotoxic effects 62 busulfan 62 azoles 62 antimitotic 62 benzimidazole 62 apoptosis inducing 62 Cremophor 62 Cytotoxic 62 ENMD # 62 glioma cells 62 #HT#A 62 HER2 receptor 62 intravenously administered 62 somatostatin analogues 62 anticancer therapy 62 CYC# 62 FK# 62 DNA intercalator 62 alkylating agents 62 OXi# 62 G CSF 62 BAL# [001] 62 Irinotecan 62 systemic antifungal 62 PXD# 62 Taxol ® 62 pharmacokinetic properties 62 bevacizumab Avastin ® 62 hematological cancers 62 GRN#L 61 pro angiogenic 61 AEG# 61 drug zotarolimus 61 radiolabeled 61 immune stimulatory 61 echinocandin 61 gemcitabine cisplatin 61 bortezomib Velcade 61 Voreloxin 61 CLL cells 61 antitumor efficacy 61 sphingosine 1 61 panobinostat 61 active metabolite 61 targeting CD# 61 active moiety 61 bactericidal activity 61 antiproliferative activity 61 GAP #B# 61 polymerase inhibitors 61 tegafur 61 immunomodulation 61 gemcitabine Gemzar 61 VEGF inhibitors 61 anticancer therapies 61 DACH platinum 61 Hsp# inhibitors 61 vWF 61 imatinib Gleevec ® 61 direct thrombin inhibitors 61 cilengitide 61 ERK signaling 61 factor G CSF 61 prostanoid 61 CYP #A# 61 MEK inhibitors 61 anti CD3 61 amikacin 61 PEGylated 61 receptor antagonists 61 kinase inhibitor 61 immune modulating 61 decitabine 61 alkylating 61 camptothecin 61 chimeric monoclonal antibody 61 flavopiridol 61 monoclonal antibody 61 VEGFR2 61 retapamulin 61 replicon 61 selective inhibitors 61 Bortezomib 61 virus AAV 61 antiproliferative effects 61 cetuximab Erbitux R 61 DHFR 61 antiangiogenesis 61 JAK2 inhibitors 61 anti resorptive 61 EGFR 61 pertussis toxin 61 anti secretory 61 anti angiogenic agent 61 glycosylated 61 thrombopoietin 61 pertuzumab 61 nucleoside analog 61 orally dosed 61 IL 1ß 61 potent antibacterial 61 radioprotective 61 vorinostat 61 Bleomycin 61 M1 muscarinic 61 nephrotoxic 61 Gleevec resistant 61 systemic absorption 61 amphotericin B 61 immune modulators 61 trans retinoic acid 61 Gemcitabine 61 PI3K inhibitors 61 triphosphate 61 small molecule inhibitors 61 antibody 61 interferons 61 adenoviral 61 GHRH 61 beta lactam antibiotics 61 Seliciclib 60 RAF kinase 60 liposomal formulation 60 PSMA ADC 60 bispecific 60 antiapoptotic 60 metastatic RCC 60 inhibits protein synthesis 60 mAbs 60 rhIL 7 60 Vidaza azacitidine 60 dihydrofolate reductase 60 insulin sensitizing 60 LHRH agonist 60 nanomolar range 60 Aβ 60 pegfilgrastim 60 NF kappaB activation 60 JAK inhibitors 60 immunotoxin 60 vitro cytotoxicity 60 pyrimidine 60 Temozolomide 60 lysosomal 60 IMC A# 60 immune modulatory 60 AKT inhibitor 60 CTLA 4 60 CYP3A 60 receptor inhibitor 60 antidiabetic 60 receptor subtype 60 marketed EGFR 60 humanized anti 60 oral antiviral 60 c MYC 60 Dasatinib 60 serine protease 60 sorafenib Nexavar 60 depsipeptide 60 Cloretazine R 60 Tarvacin 60 Fas ligand 60 cardiotoxic 60 mycophenolate mofetil 60 auristatin 60 macrolide antibiotics 60 trans retinoic acid ATRA 60 tigecycline 60 granisetron 60 dasatinib Sprycel 60 IL #p# 60 iNOS 60 N methyl 60 pan HDAC inhibitor 60 trastuzumab Herceptin 60 osteoinductive 60 IFN alpha 60 non nucleoside 60 CDK inhibitor 60 inhibitory activity 60 bendamustine 60 CsA 60 prodrugs 60 antiangiogenic activity 60 small molecule tyrosine 60 immunosuppressant 60 5 fluorouracil 60 vasodilatory 60 tumor cells 60 potent anti angiogenic 60 5 FU 60 cidofovir 60 nucleosides 60 androgen receptor AR 60 EGFR inhibitors 60 chemotherapies 60 NKG2D 60 daunorubicin 60 monomeric 60 imetelstat 60 imatinib mesylate 60 TACE 60 anti apoptotic 60 ADP receptor antagonist 60 albumin bound paclitaxel 60 hepatoma 60 PC# cells 60 CD# expressing 60 Zysolin TM 60 HuLuc# 60 activate p# 60 TREANDA 60 kinase inhibitors 60 targeted antifolate 60 cyclin dependent kinase inhibitor 60 oxidative stress inducer 60 immune modulator 60 Vorinostat 60 humanized monoclonal antibodies 60 #ME# 60 anthracyclines 60 biodistribution 60 Interferon alfa 60 lipophilic 60 liposomal 60 Neulasta ® 60 ESBA# 60 partial agonist 60 sunitinib Sutent ® 60 ERK1 2 60 cetuximab Erbitux ® 60 NEUGENE 60 Hycamtin 60 Pertuzumab 60 anti fibrotic 60 factor TNF 60 colon carcinoma 60 Zolinza 60 Taxotere ® 60 lanreotide 60 HCV protease 60 bicalutamide 60 cathepsins 60 antiandrogen 60 paclitaxel 60 plasmin 60 L asparaginase 60 Azedra 60 multikinase inhibitor 60 peripherally acting 60 angiogenesis inhibitor 60 CYT# potent vascular disrupting 60 XmAb# 60 immunomodulators 60 RNAi compounds 60 FGFR 60 OMP #M# 60 cyclophosphamide 60 selectively inhibits 60 cytotoxic T lymphocyte 60 VEGF pathway 60 survivin 60 HCV replicon 60 phosphate S1P 60 potent inhibitor 60 intratumoral injection 60 liposomal doxorubicin 60 chemically modified siRNA 60 PGE2 60 chemotherapeutic regimen 60 genotoxic 60 polymerase inhibitor 60 potentially hepatotoxic 60 receptor tyrosine kinase inhibitor 60 REP# 60 MAb 60 Docetaxel 60 5alpha reductase 60 immunotherapeutic 60 topotecan 60 TGF beta1 60 seliciclib 59 triphendiol 59 CDDO Im 59 uric acid lowering 59 factor Xa inhibitor 59 cytotoxics 59 NEUGENE antisense 59 interferon beta 59 lenalidomide Revlimid R 59 Aurora kinase 59 Mitoxantrone 59 anti neoplastic 59 TKIs 59 HGS ETR2 59 eNOS 59 estramustine 59 HER1 59 peptidic 59 PARP inhibitors 59 neurotoxicity 59 cytolytic 59 Orally administered 59 CD# antibody [001] 59 Squalamine 59 docetaxel Taxotere ® 59 heparanase 59 EP1 receptor 59 isoproterenol 59 HER3 59 BiTE 59 potently inhibited 59 fusion proteins 59 fulvestrant 59 PARP inhibitor 59 isotypes 59 relapsed ovarian cancer 59 gastrin 59 endoxifen 59 HDAC6 59 cytarabine 59 BRAF kinase 59 PDGFR 59 pegylated liposomal doxorubicin 59 mapatumumab 59 osteogenic 59 ganetespib 59 Cyclosporine 59 tyrosine kinase inhibitors 59 vascular disrupting agent 59 radiolabeled monoclonal antibody 59 5 HT2B receptor 59 Carfilzomib 59 DepoVax 59 HGS# 59 partial agonists 59 tumor vasculature 59 docetaxel Taxotere 59 TRAIL receptors 59 histone deacetylase inhibitors 59 alveolar epithelial cells 59 neurotrophic 59 NNRTIs 59 EphA2 59 WT1 59 metalloprotease 59 recombinant protein 59 superficial bladder cancer 59 receptor activation 59 eIF4E 59 Blinatumomab 59 IGF 1R 59 chemoprotective 59 DiLA2 59 lapatinib Tykerb 59 favorable pharmacokinetic profile 59 TGF ß 59 somatostatin 59 investigational humanized monoclonal antibody 59 luteinizing hormone releasing 59 oncoprotein 59 cell lysis 59 anti EGFR antibody 59 potent antiviral 59 anticancer treatments 59 oncoproteins 59 gemcitabine carboplatin 59 EpCAM 59 Aplidin 59 adipogenic 59 proteasome inhibitor bortezomib 59 obatoclax 59 alpha interferon 59 photosensitizers 59 Th2 cytokines 59 solid tumors 59 antisense oligonucleotides 59 CD# receptor 59 beta adrenergic 59 Telintra 59 paclitaxel Taxol ® 59 polyethylene glycol PEG 59 cytotoxic T lymphocytes 59 gamma secretase inhibitors 59 Imatinib 59 CCR9 59 Liposomal 59 monoclonal antibody mAb 59 IFN α 59 Bevacizumab 59 Symadex 59 gemcitabine Gemzar ® 59 mitogen activated protein kinase 59 antithrombotic 59 cytotoxin 59 Monoclonal antibodies 59 adriamycin 59 hedgehog pathway 59 ara C 59 receptor agonists 59 R baclofen 59 proteolytic enzymes 59 fluoropyrimidine 59 EGFR antibodies 59 tumorigenicity 59 potent inhibitors 59 poly ADP ribose polymerase 59 Paraplatin ® carboplatin 59 HCV protease inhibitors 59 pRb 59 pDCs 59 CBLC# 59 mineralocorticoid 59 gemcitabine 59 59 CCX# 59 ansamycin 59 interferon alpha 59 PDGF BB 59 EGFR HER2 59 IMGN# 59 iobenguane 59 glycolipids 59 T#I mutant 59 systemically administered 59 azacitidine 59 brostallicin 59 topoisomerase II inhibitor 59 IgG1 59 intravesical instillation 59 IL #E 59 kinase inhibition 59 glucocorticoid receptor 59 monoclonal antibodies 59 mAb 59 Darinaparsin 59 administered systemically 59 Akt activation 59 EZN 59 antitumour 59 histone deacetylase HDAC inhibitors 59 cyclosporin 59 histone deacetylase HDAC inhibitor 59 thalidomide Thalomid 59 TRAIL R2 59 liposome encapsulated 59 posaconazole 59 Raltegravir 59 beta lactams 59 immuno modulatory 59 OncoVEX GM CSF 59 immune suppressive 59 ISTODAX 59 histone deacetylases 59 S/GSK# 59 CRAC channel 59 inhibited tumor 59 IFN gamma 59 azole 59 phenoxodiol 59 TGF alpha 59 Apo2L 59 estrogen receptor beta 59 druggable target 59 nicotinic acetylcholine receptor 59 c MET 59 heme oxygenase 59 adrenoceptor 59 Anticalins ® 58 selectively binds 58 DNA gyrase 58 tumor subtypes 58 microvascular endothelial cells 58 interferon 58 relapsed refractory 58 hypoxia inducible factor 58 mecamylamine 58 docetaxel 58 antimetastatic 58 endothelin receptor antagonists 58 goserelin 58 LPA1 receptor 58 dephosphorylation 58 PDE4 inhibitors 58 Fluorouracil 58 liposomes 58 Paclitaxel 58 JAK#/JAK# 58 Epothilones 58 CCL# 58 oral prodrug 58 systemic toxicity 58 HDAC inhibitor 58 NFκB 58 AMPK activators 58 hapten 58 therapeutically relevant 58 polyketides 58 unconjugated 58 protein kinase inhibitor 58 beta lactam antibiotic 58 histone deacetylase HDAC 58 delta isoform 58 Fc fusion protein 58 LY# [003] 58 NS#/#A protease 58 itraconazole 58 annexin V 58 HGS ETR1 58 interferon alfa 2b 58 act synergistically 58 TRAIL induced apoptosis 58 HSP# inhibitors 58 cytokine secretion 58 macrolide antibiotic 58 Chemokine Receptor 58 carboplatin paclitaxel 58 IL 1beta 58 Onconase 58 multi kinase inhibitor 58 peroxisome proliferator activated 58 BCR ABL 58 PRT# 58 PAK1 58 HepG2 cells 58 Cloretazine VNP#M 58 xenografts 58 resolvins 58 activin 58 prostaglandin D2 58 Pathway Inhibitor 58 anti angiogenic agents 58 PDGF receptor 58 bevacizumab Avastin R 58 phosphorylate 58 MGd 58 Epirubicin 58 tyrosine kinase inhibitor TKI 58 bone marrow suppression 58 Lenalidomide 58 stable nucleic acid 58 selective kinase inhibitor 58 LEP ETU 58 PPARgamma 58 mitogenic 58 BAY #-# 58 ACh 58 apoptotic cells 58 humanised monoclonal antibody 58 MDM2 58 chemopreventive 58 protease inhibitor 58 nanoparticulate 58 FLT3 58 synthase TS 58 colony stimulating factor 58 ENMD 58 dimerization 58 cyclooxygenase 58 PC3 cells 58 chemopreventive agent 58 intratumoral 58 Angiolix 58 biologic therapeutics 58 glioblastoma cells 58 Tumor Necrosis Factor 58 bortezomib Velcade ® 58 enveloped viruses 58 MTP inhibitor 58 CD#L 58 preclinically 58 tubulin polymerization 58 QbG# 58 deacetylation 58 TRV# [001] 58 potent inhibition 58 adrenergic receptors 58 equimolar 58 ISF# 58 talabostat 58 Pegylated 58 murine 58 ENaC 58 antisense oligonucleotide 58 nucleotide analogs 58 TKI therapy 58 interleukin IL -# 58 calcitriol 58 thymidylate synthase TS 58 mitomycin 58 parthenolide 58 laropiprant 58 MDSCs 58 Homspera 58 mitochondrial toxicity 58 cleavable linker 58 radiotherapeutic 58 thymalfasin 58 GSK3B 58 tumor antigens 58 related apoptosis inducing 58 HDAC 58 Cloretazine 58 conjugates 58 oral antidiabetic 58 vidofludimus 58 nucleoside analogue 58 pomalidomide 58 retinoid 58 fungicidal 58 metastatic colorectal 58 TAFA# 58 selectively inhibited 58 hematologic malignancies 58 demonstrated antitumor activity 58 CD# protein 58 Vandetanib 58 tolerogenic 58 selective modulator 58 Sym# 58 Cytoxan 58 mitomycin C 58 Everolimus 58 thapsigargin 58 dose cytarabine 58 hepatotoxic 58 immunotoxins 58 IgG1 antibody 58 liposome formulation 58 mda 7 58 selective agonist 58 Pgp 58 Taxotere docetaxel 58 antifolate 58 adrenocorticotropic hormone ACTH 58 nonsteroidal 58 Epidermal Growth Factor Receptor 58 incretin 58 Galectin 58 SIRT2 58 novel immunomodulatory 58 DAVANAT 58 biologic therapy 58 peptibody 58 IgG antibodies 58 demethylating agent 58 ofloxacin 58 bevacizumab Avastin 58 lenalidomide dexamethasone 58 pathophysiological effects 58 inhibit tumor angiogenesis 58 soluble receptor 58 nanocarrier 58 tositumomab 58 Fludara 58 Omacetaxine 58 receptor mediated 58 corticosteroid dexamethasone 58 constitutively active 58 selective orally bioavailable 58 tumoral 58 K ras mutations 58 cisplatin chemotherapy 58 elastase 58 recombinant antibodies 58 inhibit EGFR 58 biologic DMARD 58 Trabectedin 58 vimentin 58 retinoic acid 58 assay detects 58 Panzem R NCD 58 hydrolase 58 acetylcholinesterase AChE 58 NF kB pathway 58 antifungal agent 58 MEK1 58 somatostatin receptors 58 activated lymphocytes 58 BMS # 58 protease inhibitors 58 Pazopanib 58 syngeneic 58 reverse transcriptase inhibitors 58 Talabostat 58 humanized monoclonal 58 siRNA mediated 58 p# activation 58 P2Y 58 hCG beta 58 paracrine 58 N cadherin 58 Carboplatin 58 CLORETAZINE TM VNP#M 58 dopamine reuptake 58 tumor antigen 58 cytochrome P# #A# 58 interferon lambda 58 hormone LHRH antagonist 58 panitumumab Vectibix 58 intracellular 58 adenosine receptor 58 integrin receptors 58 indibulin 58 lapatinib 58 glycosylation profile 58 uPA 58 leucovorin 58 Valortim R 58 Capecitabine 58 granulocyte colony stimulating 58 TLR agonists 58 interferon alfa 58 TNF Tumor Necrosis Factor 58 TELINTRA 58 sodium glucose cotransporter 58 dacarbazine 58 PEG SN# 58 menadione 58 Elvitegravir 58 antifibrotic 58 amifostine 58 Imprime PGG 58 inhibit viral replication 58 solithromycin 58 osteoblast 58 radionuclide therapy 58 Preclinical studies 58 AAG geldanamycin analog 58 antiangiogenic agent 58 non selective NMDA 58 inhibitor RG# 58 antiangiogenic therapy 58 DXL# 58 voriconazole 58 CD4 + CD# 58 vascular endothelial cells 57 CB1 receptor 57 fusion protein 57 glutamate receptors 57 tyrosine kinase 57 neuroblastoma cells 57 quinolone 57 rifamycin 57 Platinol ® cisplatin 57 overlapping toxicities 57 B CLL 57 acetylcholinesterase 57 standard chemotherapy regimens 57 novel orally bioavailable 57 cisplatin resistant 57 prostaglandin E2 PGE2 57 dexamethasone Decadron 57 irinotecan hydrochloride 57 peroxynitrite 57 chemotherapeutic regimens 57 tumor vascular disrupting 57 anti amnesic 57 p# mitogen activated 57 TNFalpha 57 anti tumoral 57 monoclonal anti 57 immune modulation 57 miconazole 57 erlotinib Tarceva 57 AMN# [001] 57 CHO cells 57 Traficet EN 57 xenograft tumors 57 CTGF 57 sulindac 57 Notch1 57 inducing apoptosis 57 HDAC inhibitors 57 transgene expression 57 phosphatidylinositol 3 57 antiandrogens 57 immunosuppressive agents 57 tumor xenograft models 57 Kahalalide F 57 inverse agonist 57 highly selective endothelin 57 topical antifungal 57 PKC# 57 sorafenib 57 heavily pretreated patients 57 RANK Ligand 57 durable remissions 57 HMG CoA reductase inhibitors 57 mononuclear 57 T#I [002] 57 alefacept 57 mertansine 57 NMDA antagonist 57 doxorubicin HCl 57 Nexavar ® 57 Tamibarotene 57 IAP inhibitors 57 VEGFb 57 cytochrome P# 57 anti angiogenic drugs 57 gastrointestinal stromal tumors GISTs 57 apoptosis induced 57 DFMO 57 ceftazidime 57 orally administered inhibitor 57 drug metabolizing enzyme 57 #beta estradiol 57 bradykinin 57 doxorubicin Adriamycin 57 vascular disrupting 57 pharmacodynamic properties 57 synthetic peptides 57 recombinant erythropoietin 57 costimulation 57 mouse xenograft models 57 caveolin 1 57 immunoconjugate 57 LTB4 57 veltuzumab 57 BChE 57 mu opioid receptor antagonist 57 antimetabolites 57 MEK ERK 57 Ceflatonin 57 acadesine 57 MGCD# [001] 57 inhibitory effect 57 leukotriene 57 ErbB2 57 PI3K Akt 57 effector functions 57 pyrophosphate 57 anti tubercular 57 cytokine IL 57 p# subunit 57 gemtuzumab ozogamicin 57 thrombogenic